<DOC>
	<DOCNO>NCT00759824</DOCNO>
	<brief_summary>The primary aim study determine addition valproic acid combination adriamycin , cyclophosphamide vindesine could increase progression-free survival patient relapse first-line chemotherapy include platinum derivative , cisplatin carboplatin , etoposide .</brief_summary>
	<brief_title>A Phase II Study Doxorubicin , Cyclophosphamide Vindesine With Valproic Acid Patients With Refractory Relapsing Small Cell Lung Cancer After Platinum Derivatives Etoposide</brief_title>
	<detailed_description />
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vindesine</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Histological cytological diagnosis smallcell lung cancer ( SCLC ) SCLC refractory prior chemotherapy regimen include platinum derivative ( cisplatin carboplatin ) etoposide , either primary refractory ( immediate progression recurrence le 3 month end previous chemotherapy ) secondary refractory ( sensitive patient platinum plus etoposide firstline , progress recur less 3 month reintroduction chemotherapy ) . At least one evaluable measurable lesion Availability participate detailed followup protocol Signed informed consent . Patient previously treat anthracyclin vincaalcaloid derivative cyclophosphamide Performance status &lt; 60 Karnofsky scale A history prior malignant tumour , except nonmelanoma skin cancer situ carcinoma cervix bladder cure malignant tumour ( 5year disease free interval ) A history prior HIV infection Polynuclear cell &lt; 2,000/mm³ Platelet cell &lt; 100,000/mm³ Abnormal coagulation test ( aPTT , PTT , prothrombin time ) and/or decrease fibrinogen Serum bilirubin &gt; 1.5 mg/100 ml Transaminases twice normal range Serum creatinine &gt; 1.5 mg/100 ml Recent myocardial infarction ( le 3 month prior date diagnosis ) Congestive cardiac failure ( ejection fraction leave ventricle &lt; 50 % ) uncontrolled cardiac arrhythmia Uncontrolled infectious disease Active epilepsy need specific treatment Concomitant treatment IMAO , carbamazepine , mefloquine , phenobarbital , primidone , phenytoïn , lamotrigine , zidovudine Pregnancy refusal use active contraception A known allergy valproic acid and/or doxorubicin , cyclophosphamide , vindesine Serious medical psychological factor may prevent adherence treatment schedule .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Small cell lung carcinoma</keyword>
	<keyword>Valproic acid</keyword>
	<keyword>Adriamycin</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Vindesine</keyword>
	<keyword>Second-line chemotherapy</keyword>
</DOC>